$396 Million is the total value of Anson Funds Management LP's 76 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DPW | Exit | DPW HLDGS INC | $0 | – | -738,138 | -100.0% | -0.15% | – |
| VISL | Exit | VISLINK TECHNOLOGIES INC | $0 | – | -765,593 | -100.0% | -0.19% | – |
| CYTXZ | Exit | CYTORI THERAPEUTICS INC*w exp 05/28/202 | $0 | – | -1,038,600 | -100.0% | -0.19% | – |
| TRNX | Exit | TARONIS TECHNOLOGIES INC | $0 | – | -940,334 | -100.0% | -0.41% | – |
| SPG | Exit | SIMON PPTY GROUP INC NEW | $0 | – | -3,850 | -100.0% | -0.49% | – |
| TMDI | Exit | TITAN MED INC | $0 | – | -312,458 | -100.0% | -0.61% | – |
| GNUS | Exit | GENIUS BRANDS INTL INC | $0 | – | -552,337 | -100.0% | -0.75% | – |
| OSTK | Exit | OVERSTOCK COM INC DELcall | $0 | – | -73,200 | -100.0% | -0.84% | – |
| NXE | Exit | NEXGEN ENERGY LTD | $0 | – | -616,400 | -100.0% | -0.92% | – |
| OGEN | Exit | ORAGENICS INC | $0 | – | -2,980,464 | -100.0% | -1.21% | – |
| OSTK | Exit | OVERSTOCK COM INC DEL | $0 | – | -371,059 | -100.0% | -4.27% | – |
| TDOC | Exit | TELADOC HEALTH INCput | $0 | – | -116,000 | -100.0% | -4.47% | – |
| NVDA | Exit | NVIDIA CORPput | $0 | – | -125,000 | -100.0% | -15.56% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 27 | Q3 2023 | 8.7% |
| BK OF AMERICA CORP | 24 | Q3 2023 | 15.9% |
| JPMORGAN CHASE & CO | 17 | Q2 2022 | 2.2% |
| MEDIGUS LTD | 17 | Q1 2023 | 0.0% |
| WISDOMTREE TR | 15 | Q2 2018 | 4.0% |
| RANDGOLD RES LTD | 15 | Q2 2018 | 3.3% |
| GRANITE REAL ESTATE INVT TR | 15 | Q3 2023 | 1.3% |
| BROOKFIELD ASSET MGMT INC | 15 | Q3 2022 | 1.3% |
| CENTRAL FD CDA LTD | 14 | Q1 2018 | 1.6% |
| MEI PHARMA INC | 14 | Q1 2023 | 1.2% |
View Anson Funds Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Appreciate Holdings, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Equity Distribution Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| GO Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| LogicMark, Inc. | February 14, 2023 | 987,399 | 9.9% |
| Model Performance Acquisition CorpSold out | February 14, 2023 | 0 | 0.0% |
| Mudrick Capital Acquisition Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| View, Inc. | February 14, 2023 | 24,597,185 | 9.9% |
| Amarantus Bioscience Holdings, Inc. | April 18, 2022 | 14,176,424 | 5.0% |
| Dune Acquisition Corp | February 11, 2022 | 100,000 | 0.6% |
| PROPTECH INVESTMENT CORP. II | February 11, 2022 | 1,184,276 | 5.2% |
View Anson Funds Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| SC 13D/A | 2024-04-05 |
| DFAN14A | 2024-04-04 |
| 4 | 2024-02-26 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View Anson Funds Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.